Scientists from Lancaster and Pisa Universities have developed a method for detecting skin cancer using a laser Doppler system, potentially reducing the need for invasive biopsies.
The research, published in Nature Scientific Reports, details how the laser Doppler system is able to detect subtle differences in blood flow beneath malignant and non-malignant moles. From 55 patients with atypical melanoma, the laser Doppler signal correctly identified 100 per cent of those with malignant skin.
“We used our knowledge of blood flow dynamics to pick up on markers which were consistently different in the blood vessels supplying malignant moles and those beneath normal skin,” said Prof Aneta Stefanovska of Lancaster University.
“Combining the new dynamical biomarkers we created a test which, based on the number of subjects tested to date, has 100 per cent sensitivity and 90.9 per cent specificity, which means that melanoma is identified in all cases where it is present, and ruled out in 90.9 per cent of cases where it is not.”
The laser test takes approximately 30 minutes. Once complete, the fluctuations in recorded signals are analysed using methods developed by physicists at Lancaster University. In the case of this study, the patients subsequently had their moles biopsied to ascertain the accuracy of the laser test, but the researchers believe the technique could dramatically reduce the need for biopsies in the future.
“Skin malignant melanoma is a particularly aggressive cancer associated with quick blood vessel growth which means early diagnosis is vital for a good prognosis,” said Prof Marco Rossi from Pisa University.
“The current diagnostic tools of examination by doctors followed by biopsy inevitably leads to many unnecessary invasive excisions. This simple, accurate, in vivo distinction between malignant melanoma and atypical moles may lead to a substantial reduction in the number of biopsies currently undertaken.”
Interesting that a new method has been found to solve a problem that has already been solved. Roughly 10 years ago a company called Armstrong had developed a 10 wavelength optical technology that also gave 100% correct classification of melanomas. It was turned into a product but sadly they were no able to convince dermatologists to use it. The problem may have been that a dermatologist had no role – an 8 year old could have operated the device. It also eliminated a huge number of unnecessary biopsies which were a major source of income for the dermatologists… So the real problem that needs solving is how to get turkeys to vote for Christmas.